Dare Bioscience, Inc. — Form 8-K
Filed July 24, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Filed 8-K on 2026-07-24 containing Regulation FD Disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). The filing includes 39 graphics and exhibits but the actual disclosure content is not provided in this index—only the document structure and file names are visible. Without access to the substantive content of ex99-1.htm or the graphics, the nature and magnitude of the disclosed event cannot be determined.
Why this rating
Cannot assess material impact without disclosure content. Filing structure alone is routine administrative disclosure; substance unknown from this index.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from July 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.